A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Illumina, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 174,700 shares of ILMN stock, worth $25.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174,700
Previous 169,300 3.19%
Holding current value
$25.5 Million
Previous $23.2 Million 21.56%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.05 - $133.57 $71.5 Million - $94.4 Million
-707,086 Reduced 62.39%
426,303 $44.5 Million
Q1 2024

May 15, 2024

BUY
$127.73 - $147.2 $90.3 Million - $104 Million
706,736 Added 165.65%
1,133,389 $156 Million
Q4 2023

Feb 14, 2024

SELL
$92.79 - $142.53 $81.8 Million - $126 Million
-881,950 Reduced 67.4%
426,653 $59.4 Million
Q3 2023

Nov 14, 2023

BUY
$128.91 - $192.44 $105 Million - $157 Million
818,304 Added 166.9%
1,308,603 $180 Million
Q2 2023

Aug 14, 2023

SELL
$183.43 - $232.67 $98 Million - $124 Million
-534,260 Reduced 52.15%
490,299 $91.9 Million
Q1 2023

May 15, 2023

SELL
$193.75 - $232.55 $68.7 Million - $82.4 Million
-354,488 Reduced 25.71%
1,024,559 $238 Million
Q4 2022

Feb 14, 2023

BUY
$187.24 - $242.74 $15.6 Million - $20.3 Million
83,444 Added 6.44%
1,379,047 $279 Million
Q3 2022

Nov 14, 2022

BUY
$177.23 - $227.44 $22.9 Million - $29.4 Million
129,105 Added 11.07%
1,295,603 $247 Million
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $66.8 Million - $135 Million
368,055 Added 46.1%
1,166,498 $215 Million
Q1 2022

May 16, 2022

BUY
$303.87 - $423.8 $28.3 Million - $39.5 Million
93,287 Added 13.23%
798,443 $279 Million
Q4 2021

Feb 14, 2022

BUY
$347.28 - $421.83 $175 Million - $212 Million
503,649 Added 249.94%
705,156 $268 Million
Q3 2021

Nov 15, 2021

BUY
$405.61 - $524.84 $42.6 Million - $55.2 Million
105,126 Added 109.07%
201,507 $81.7 Million
Q2 2021

Aug 16, 2021

SELL
$372.84 - $481.5 $57.8 Million - $74.7 Million
-155,037 Reduced 61.67%
96,381 $45.6 Million
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $25.1 Million - $35.1 Million
69,512 Added 38.21%
251,418 $96.6 Million
Q4 2020

Feb 16, 2021

BUY
$292.7 - $370.96 $3.52 Million - $4.46 Million
12,013 Added 7.07%
181,906 $67.3 Million
Q3 2020

Nov 16, 2020

BUY
$268.51 - $400.74 $38.1 Million - $56.8 Million
141,763 Added 503.96%
169,893 $52.5 Million
Q2 2020

Aug 14, 2020

SELL
$256.46 - $373.01 $5.58 Million - $8.11 Million
-21,742 Reduced 43.6%
28,130 $10.4 Million
Q1 2020

May 15, 2020

SELL
$209.2 - $335.53 $13 Million - $20.9 Million
-62,354 Reduced 55.56%
49,872 $13.6 Million
Q4 2019

Feb 14, 2020

SELL
$288.29 - $335.49 $138 Million - $161 Million
-479,586 Reduced 81.04%
112,226 $37.2 Million
Q3 2019

Nov 14, 2019

BUY
$266.84 - $378.23 $71.2 Million - $101 Million
266,693 Added 82.03%
591,812 $180 Million
Q2 2019

Aug 14, 2019

BUY
$300.59 - $368.15 $85.7 Million - $105 Million
285,180 Added 714.04%
325,119 $120 Million
Q1 2019

May 15, 2019

SELL
$272.57 - $321.18 $6.59 Million - $7.76 Million
-24,173 Reduced 37.7%
39,939 $0
Q4 2018

Feb 14, 2019

SELL
$272.46 - $366.54 $51.6 Million - $69.4 Million
-189,344 Reduced 74.7%
64,112 $19.2 Million
Q3 2018

Nov 13, 2018

BUY
$279.04 - $367.06 $7.32 Million - $9.63 Million
26,245 Added 11.55%
253,456 $0
Q2 2018

Aug 10, 2018

BUY
$228.17 - $292.07 $33.2 Million - $42.5 Million
145,469 Added 177.96%
227,211 $0
Q1 2018

May 11, 2018

BUY
$209.54 - $253.91 $874,619 - $1.06 Million
4,174 Added 5.38%
81,742 $19.3 Million
Q4 2017

Feb 09, 2018

SELL
$202.23 - $230.03 $52.2 Million - $59.3 Million
-257,965 Reduced 76.88%
77,568 $16.9 Million
Q3 2017

Nov 09, 2017

BUY
$172.3 - $213.93 $57.8 Million - $71.8 Million
335,533
335,533 $66.8 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $23B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.